Halothane inhibits the microbicidal oxidative activity of pulmonary alveolar macrophages

Anesthesiology
|May 1, 1983
PubMed

Insights

Clinical halothane concentrations impair pulmonary alveolar macrophage (PAM) oxidative activity, reducing key microbicidal intermediates. This inhibition is reversible upon halothane removal, suggesting potential for recovery.

Area of Science:

  • Immunology
  • Anesthesiology
  • Cell Biology

Background:

  • Pulmonary alveolar macrophages (PAMs) are crucial for lung immunity.
  • Halothane is an anesthetic agent with potential cellular effects.
  • Oxidative activity of PAMs is vital for microbicidal function.

Purpose of the Study:

  • To investigate the impact of clinical halothane concentrations on PAM oxidative activity.
  • To assess the generation of hydrogen peroxide (H2O2), hydroxyl radicals (OH), and superoxide anions (O2-) by PAMs.
  • To determine the reversibility of halothane's effects on PAM function.

Main Methods:

  • Pulmonary alveolar macrophages (PAMs) were exposed to varying concentrations of halothane.
  • Chemiluminescence (CL) assays using luminol and lucigenin probes were employed.
  • Luminol CL measured overall oxidative activity (H2O2, OH, O2-), while lucigenin CL specifically measured O2- generation.

Main Results:

  • Halothane exposure significantly inhibited both luminol and lucigenin CL responses in PAMs (P < 0.01).
  • Inhibition ranged from 23-46% for luminol and 30-51% for lucigenin.
  • PAMs showed significant recovery of luminol CL responses after halothane removal, indicating reversibility.

Conclusions:

  • Clinical halothane concentrations decrease the generation of superoxide anions and other oxidative metabolites by PAMs.
  • The observed inhibition of PAM microbicidal oxidative activity by halothane is reversible.
  • These findings have implications for understanding the immunomodulatory effects of halothane anesthesia.

Related Concept Videos

Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Chemical Agents for Microbial Control01:27

Chemical Agents for Microbial Control

Chemicals play important roles in controlling microbial growth by targeting microbial structures and functions as sanitizers, antiseptics, disinfectants, and sterilants.Alcohols are commonly used sanitizers, effectively disrupting lipid membranes, which compromises cell integrity. They are also used as antiseptics and disinfectants due to their rapid action and versatility.Phenols and their derivatives phenolics , known for denaturing proteins and disrupting cell membranes, are particularly...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.